Abstract:Objective: The objective of this study is to evaluate the efficacy of somatostatin, ulinastatin and gabexate for the treatment of severe acute pancreatitis. Materials and methods: A total of 492 patients with severe acute pancreatitis were assigned randomly into the following 4 groups: (1) somatostatin; (2) somatostatin + ulinastatin; (3) somatostatin + gabexate and (4) somatostatin + ulinastatin + gabexate. Acute physiology and chronic health evaluation II scores; clinical parameters including time of abdominal pain and distention extinct; recovering to normality of heart rate and respiration rate; amylase and blood glucose; ratios of efficacy; multiple organ dysfunction syndrome (MODS); mortality; complication; levels of endotoxin; tumor necrosis factor alpha; interleukin-6 (IL-6), IL-8 and IL-10 and side effects were analyzed. Results: Acute physiology and chronic health evaluation II scores, time of abdominal pain extinct and distention extinct, time of recovering to normality of heart rate, time of recovering to normality of respiration rate and time of recovering to normality of amylase and blood glucose were significantly decreased in the somatostatin + ulinastatin, the somatostatin + gabexate and the somatostatin + ulinastatin + gabexate subgroups compared with the somatostatin subgroup. Ratios of efficacy were significantly improved, whereas ratios of MODS, mortality and complication were significantly decreased in the somatostatin + ulinastatin and the somatostatin + ulinastatin + gabexate subgroups compared with the somatostatin subgroup. Tumor necrosis factor alpha, IL-6 and IL-8 levels on the fourth day after treatment showed significant decrease in the somatostatin + ulinastatin, the somatostatin + gabexate and the somatostatin + ulinastatin + gabexate subgroups compared with the somatostatin subgroup. The IL-10 levels on the fourth day were significantly improved in the somatostatin + ulinastatin, the somatostatin + gabexate and the somatostatin + ulinastatin + gabexate subgroups compared with the somatostatin subgroup. Conclusions: Somatostatin is effective for the treatment of acute pancreatitis, ulinastatin demonstrates improvement in therapeutic benefits and gabexate can relieve the clinical symptoms and shorten the course of disease but cannot improve the effective ratio or decrease MODS, mortality and complication.

Clinical study of somatostatin combined with raw vegetable oil in treatment of intestinal obstruction

The Clinical Observation of Chinese and Western Medicine Combined with Laparoscopic Surgery and Minimally Invasive Treatment of Acute Intestinal Obstruction

The Effect of Somatostatin on the Internal Environment in Patients with Intestinal Obstruction

Gastrointestinal Tumor Diagnosis and Treatment of Early Postoperative Inlfammatory Intestinal Obstruction

Curative effect observation of somatostatin in the non-surgical treatment of malignant bowel obstruction caused by gastroenteric tumor

Application of Somatostatin Combined with Oral Vancomycin in the Treatment of Intestinal Obstruction after Liver Transplantation

Comparison of Integrated Chinese and Western Medicine with and Without Somatostatin Supplement in the Treatment of Severe Acute Pancreatitis.

Systematic Review on Somatostatin Combined with Omeprazole for Treating Acute Pancreatitis

Effect of Somatostatin in Advanced Gastric Cancer after D2 Radical Gastrectomy

CLINICAL STUDY OF THE CURATIVE EFFECT OF SOMATOSTATIN COMBINES WITH PANCREATIC CLEAR SOUP ON 70 CASES OF ACUTE PANCREATITIS

Effect of somatostatin combined with compound salvia miltiorrhiza injection (复方丹参注射液) on patients with acute pancreatitis

Influence on Rehabilitation of Early Enteral Nutrition combined with Somatostatin in Patients After Pancreatodoudenectomy

Efficacy of Emergency Endoscopic Hemostasis Combined with Somatostatin in Treatment of Upper Gastrointestinal Hemorrhage

Influence of enteral nutrition combined with somatostatin on postoperative rehabilitation of patients with pancreatic surgery

Randomised Clinical Trial Investigating the Effects of Combined Administration of Octreotide and Methylglucamine Diatrizoate in the Older Persons with Adhesive Small Bowel Obstruction

Conservative Treatment of Early Postoperative Small Bowel Obstruction with Obliterative Peritonitis

Therapeutic value of sesame oil in the treatment of adhesive small bowel obstruction.

Octreotide for the Treatment of Postoperative Acute Adhesive Small Bowel Obstruction

Clinical Effect of High Dose Somatostatin, Omeprazole Combined with Hemostasis on the Acute Upper Gastrointestinal Bleeding Patients combined with Coagulation Dysfunction

Effect of Somatostatin, Ulinastatin and Gabexate on the Treatment of Severe Acute Pancreatitis

Effects of Octreotide in Patients with Bowel Obstruction